Skip to content

Clinical trials

Active, not recruiting Triple Negative Breast Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Active, not recruiting Country / region: France Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20182
20194
20204
20213
20225
20232
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
UNICANCER3
AbbVie2
Centre Jean Perrin2
Gilead Sciences2
Alterome Therapeutics, Inc.1
Atavistik Bio, Inc1
Bayer1
BicycleTx Limited1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms28
Breast Neoplasms8
Carcinoma, Non-Small-Cell Lung8
Neoplasms8
Ovarian Neoplasms7
Neoplasm Metastasis6
Melanoma5
Squamous Cell Carcinoma of Head and Neck5
Uterine Cervical Neoplasms5
Colorectal Neoplasms4

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.